The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Official Title: A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects With Localized or Locally Advanced RCC Following Nephrectomy
Study ID: NCT01235962
Brief Summary: This randomized Phase III study is to evaluate whether pazopanib compared with placebo can prevent or delay recurrence of kidney cancer in patients with moderately high or high risk of developing recurrence after undergoing kidney cancer surgery.
Detailed Description: The primary objective of this ongoing study was to evaluate DFS with pazopanib 600 mg daily initial dose as compared with placebo as adjuvant therapy for subjects with localized/locally advanced RCC following nephrectomy. Subjects with locally recurrent renal cell carcinoma (RCC), bilateral RCC, or history of another malignancy were excluded from enrolling in the study. The study was comprised of three successive study periods: 1) the Screening/Baseline period, 2) the study treatment period, and 3) the DFS /OS follow-up period. The Screening/Baseline period had a maximum duration of 12 weeks from the date of nephrectomy to the date of randomization. After a subject met all the eligibility criteria and completed all the required baseline assessments, the subject was randomized in a 1:1 ratio to receive once daily blinded treatment with either pazopanib 600 mg as initial dose or matching placebo based on pre-defined stratification factors. Subjects received continuous daily treatment until completion of the 12-month treatment period, disease recurrence, or unacceptable toxicity/intolerance. Subsequent adjuvant therapies for RCC were not allowed. During the study treatment and DFS follow-up periods, subjects received routine safety and efficacy assessments. The study treatment period was 12 months. Subjects received continuous daily treatment until completion of the 12 month treatment period, disease recurrence, or unacceptable toxicity/intolerance. Subsequent adjuvant therapies for RCC were not allowed. All subjects, regardless of study treatment status (i.e. premature discontinuation or completion of the 12-month treatment), were to be followed with routine imaging assessments and remain blinded until objective evidence of disease recurrence was obtained or until the study achieved the required number of events for the primary endpoint of DFS (319 events). After objective evidence of disease recurrence was obtained, subjects could be unblinded and received the first-line treatment for metastatic RCC per local standard of care. All subjects were off treatment for at least 4 years at the end of study.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Novartis Investigative Site, Jonesboro, Arkansas, United States
Novartis Investigative Site, Antioch, California, United States
Novartis Investigative Site, Beverly Hills, California, United States
Novartis Investigative Site, Fresno, California, United States
Novartis Investigative Site, La Jolla, California, United States
Novartis Investigative Site, Los Angeles, California, United States
Novartis Investigative Site, Los Angeles, California, United States
Novartis Investigative Site, Los Angeles, California, United States
Novartis Investigative Site, Oakland, California, United States
Novartis Investigative Site, Sacramento, California, United States
Novartis Investigative Site, San Francisco, California, United States
Novartis Investigative Site, South San Francisco, California, United States
Novartis Investigative Site, Stanford, California, United States
Novartis Investigative Site, Vallejo, California, United States
Novartis Investigative Site, Fort Collins, Colorado, United States
Novartis Investigative Site, Washington, District of Columbia, United States
Novartis Investigative Site, Fort Myers, Florida, United States
Novartis Investigative Site, Tampa, Florida, United States
Novartis Investigative Site, Athens, Georgia, United States
Novartis Investigative Site, Macon, Georgia, United States
Novartis Investigative Site, Chicago, Illinois, United States
Novartis Investigative Site, Indianapolis, Indiana, United States
Novartis Investigative Site, Iowa City, Iowa, United States
Novartis Investigative Site, Baltimore, Maryland, United States
Novartis Investigative Site, Boston, Massachusetts, United States
Novartis Investigative Site, Boston, Massachusetts, United States
Novartis Investigative Site, Boston, Massachusetts, United States
Novartis Investigative Site, Burlington, Massachusetts, United States
Novartis Investigative Site, Detroit, Michigan, United States
Novartis Investigative Site, Rochester, Minnesota, United States
Novartis Investigative Site, Saint Louis Park, Minnesota, United States
Novartis Investigative Site, Saint Louis, Missouri, United States
Novartis Investigative Site, Lincoln, Nebraska, United States
Novartis Investigative Site, Omaha, Nebraska, United States
Novartis Investigative Site, Omaha, Nebraska, United States
Novartis Investigative Site, Las Vegas, Nevada, United States
Novartis Investigative Site, Hackensack, New Jersey, United States
Novartis Investigative Site, Albany, New York, United States
Novartis Investigative Site, Buffalo, New York, United States
Novartis Investigative Site, New York, New York, United States
Novartis Investigative Site, New York, New York, United States
Novartis Investigative Site, New York, New York, United States
Novartis Investigative Site, Durham, North Carolina, United States
Novartis Investigative Site, Cincinnati, Ohio, United States
Novartis Investigative Site, Cleveland, Ohio, United States
Novartis Investigative Site, Columbus, Ohio, United States
Novartis Investigative Site, Portland, Oregon, United States
Novartis Investigative Site, Springfield, Oregon, United States
Novartis Investigative Site, Philadelphia, Pennsylvania, United States
Novartis Investigative Site, Philadelphia, Pennsylvania, United States
Novartis Investigative Site, Philadelphia, Pennsylvania, United States
Novartis Investigative Site, Philadelphia, Pennsylvania, United States
Novartis Investigative Site, Providence, Rhode Island, United States
Novartis Investigative Site, Providence, Rhode Island, United States
Novartis Investigative Site, Charleston, South Carolina, United States
Novartis Investigative Site, Chattanooga, Tennessee, United States
Novartis Investigative Site, Memphis, Tennessee, United States
Novartis Investigative Site, Nashville, Tennessee, United States
Novartis Investigative Site, Nashville, Tennessee, United States
Novartis Investigative Site, Bedford, Texas, United States
Novartis Investigative Site, Dallas, Texas, United States
Novartis Investigative Site, Houston, Texas, United States
Novartis Investigative Site, Houston, Texas, United States
Novartis Investigative Site, San Antonio, Texas, United States
Novartis Investigative Site, Tyler, Texas, United States
Novartis Investigative Site, Hampton, Virginia, United States
Novartis Investigative Site, Richmond, Virginia, United States
Novartis Investigative Site, Virginia Beach, Virginia, United States
Novartis Investigative Site, Seattle, Washington, United States
Novartis Investigative Site, Berazategui, Buenos Aires, Argentina
Novartis Investigative Site, Capital Federal, Buenos Aires, Argentina
Novartis Investigative Site, Ciudad Aut6noma de Buenos Aires, Buenos Aires, Argentina
Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Novartis Investigative Site, Quilmes, Buenos Aires, Argentina
Novartis Investigative Site, Cordoba, Córdova, Argentina
Novartis Investigative Site, Cordoba, Córdova, Argentina
Novartis Investigative Site, Cipolletti, Río Negro, Argentina
Novartis Investigative Site, Rosario, Santa Fe, Argentina
Novartis Investigative Site, San Miguel de Tucuman, , Argentina
Novartis Investigative Site, Santa Fe, , Argentina
Novartis Investigative Site, Graz, , Austria
Novartis Investigative Site, Innsbruck, , Austria
Novartis Investigative Site, Salzburg, , Austria
Novartis Investigative Site, Salzburg, , Austria
Novartis Investigative Site, Vienna, , Austria
Novartis Investigative Site, Vienna, , Austria
Novartis Investigative Site, Hasselt, , Belgium
Novartis Investigative Site, Jette, , Belgium
Novartis Investigative Site, Liege, , Belgium
Novartis Investigative Site, Namur, , Belgium
Novartis Investigative Site, Roeselare, , Belgium
Novartis Investigative Site, Wilrijk, , Belgium
Novartis Investigative Site, Belo Horizonte, Minas Gerais, Brazil
Novartis Investigative Site, Curitiba, Paraná, Brazil
Novartis Investigative Site, Ijui, Rio Grande Do Sul, Brazil
Novartis Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil
Novartis Investigative Site, Barretos, São Paulo, Brazil
Novartis Investigative Site, Campinas, São Paulo, Brazil
Novartis Investigative Site, Sao Paulo, São Paulo, Brazil
Novartis Investigative Site, Sao Paulo, São Paulo, Brazil
Novartis Investigative Site, Sao Paulo, São Paulo, Brazil
Novartis Investigative Site, Sao Paulo, São Paulo, Brazil
Novartis Investigative Site, Rio de Janeiro, , Brazil
Novartis Investigative Site, Rio de Janeiro, , Brazil
Novartis Investigative Site, Calgary, Alberta, Canada
Novartis Investigative Site, Edmonton, Alberta, Canada
Novartis Investigative Site, Vancouver, British Columbia, Canada
Novartis Investigative Site, Moncton, New Brunswick, Canada
Novartis Investigative Site, Halifax, Nova Scotia, Canada
Novartis Investigative Site, Hamilton, Ontario, Canada
Novartis Investigative Site, London, Ontario, Canada
Novartis Investigative Site, Oshawa, Ontario, Canada
Novartis Investigative Site, Ottawa, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Quebec, , Canada
Novartis Investigative Site, Santiago, Región Metro De Santiago, Chile
Novartis Investigative Site, Vina del Mar, Valparaíso, Chile
Novartis Investigative Site, Wuhan, Hubei, China
Novartis Investigative Site, Hangzhou, Zhejiang, China
Novartis Investigative Site, Hangzhou, Zhejiang, China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Tianjin, , China
Novartis Investigative Site, Brno, , Czechia
Novartis Investigative Site, Brno, , Czechia
Novartis Investigative Site, Hradec Kralove, , Czechia
Novartis Investigative Site, Novy Jicin, , Czechia
Novartis Investigative Site, Olomouc, , Czechia
Novartis Investigative Site, Ostrava - Poruba, , Czechia
Novartis Investigative Site, Plzen, , Czechia
Novartis Investigative Site, Praha 2, , Czechia
Novartis Investigative Site, Praha 8, , Czechia
Novartis Investigative Site, Usti nad Labem, , Czechia
Novartis Investigative Site, Aarhus, , Denmark
Novartis Investigative Site, Dk-2730 Herlev, , Denmark
Novartis Investigative Site, Odense C, , Denmark
Novartis Investigative Site, ANGERS Cedex 2, , France
Novartis Investigative Site, Besancon cedex, , France
Novartis Investigative Site, Bordeaux, , France
Novartis Investigative Site, Caen Cedex, , France
Novartis Investigative Site, Hyeres, , France
Novartis Investigative Site, Le Mans, , France
Novartis Investigative Site, Marseille cedex 5, , France
Novartis Investigative Site, Montpellier Cedex 5, , France
Novartis Investigative Site, Paris Cedex 15, , France
Novartis Investigative Site, Paris, , France
Novartis Investigative Site, Poitiers Cedex, , France
Novartis Investigative Site, Reims, , France
Novartis Investigative Site, Rennes, , France
Novartis Investigative Site, Saint Herblain, , France
Novartis Investigative Site, Strasbourg cedex, , France
Novartis Investigative Site, Strasbourg Cedex, , France
Novartis Investigative Site, Toulouse, , France
Novartis Investigative Site, Tours Cedex 9, , France
Novartis Investigative Site, Kirchheim, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Ravensburg, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Sigmaringen, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Stuttgart, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Tuebingen, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Ulm, Baden-Wuerttemberg, Germany
Novartis Investigative Site, Erlangen, Bayern, Germany
Novartis Investigative Site, Fuerth, Bayern, Germany
Novartis Investigative Site, Muenchen, Bayern, Germany
Novartis Investigative Site, Regensburg, Bayern, Germany
Novartis Investigative Site, Weiden, Bayern, Germany
Novartis Investigative Site, Frankfurt, Hessen, Germany
Novartis Investigative Site, Marburg, Hessen, Germany
Novartis Investigative Site, Offenbach, Hessen, Germany
Novartis Investigative Site, Braunschweig, Niedersachsen, Germany
Novartis Investigative Site, Goslar, Niedersachsen, Germany
Novartis Investigative Site, Hannover, Niedersachsen, Germany
Novartis Investigative Site, Aachen, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Bergisch Gladbach, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Bonn, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Duisburg, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Essen, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Moenchengladbach, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Muenster, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Neuss, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Velbert, Nordrhein-Westfalen, Germany
Novartis Investigative Site, Mainz, Rheinland-Pfalz, Germany
Novartis Investigative Site, Homburg, Saarland, Germany
Novartis Investigative Site, Dessau, Sachsen-Anhalt, Germany
Novartis Investigative Site, Eisleben, Sachsen-Anhalt, Germany
Novartis Investigative Site, Halle, Sachsen-Anhalt, Germany
Novartis Investigative Site, Chemnitz, Sachsen, Germany
Novartis Investigative Site, Leipzig, Sachsen, Germany
Novartis Investigative Site, Plauen, Sachsen, Germany
Novartis Investigative Site, Luebeck, Schleswig-Holstein, Germany
Novartis Investigative Site, Jena, Thueringen, Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Bremen, , Germany
Novartis Investigative Site, Hamburg, , Germany
Novartis Investigative Site, Athens, , Greece
Novartis Investigative Site, Heraklion, Crete, , Greece
Novartis Investigative Site, Patra, , Greece
Novartis Investigative Site, Thessaloniki, , Greece
Novartis Investigative Site, Budapest, , Hungary
Novartis Investigative Site, Budapest, , Hungary
Novartis Investigative Site, Budapest, , Hungary
Novartis Investigative Site, Miskolc, , Hungary
Novartis Investigative Site, Nyiregyhaza, , Hungary
Novartis Investigative Site, Szombathely, , Hungary
Novartis Investigative Site, Cork, , Ireland
Novartis Investigative Site, Dublin, , Ireland
Novartis Investigative Site, Dublin, , Ireland
Novartis Investigative Site, Galway, , Ireland
Novartis Investigative Site, Tallaght, Dublin, , Ireland
Novartis Investigative Site, Haifa, , Israel
Novartis Investigative Site, Jerusalem, , Israel
Novartis Investigative Site, Petach-Tikva, , Israel
Novartis Investigative Site, Rehovot, , Israel
Novartis Investigative Site, Tel Aviv, , Israel
Novartis Investigative Site, Zrifin, , Israel
Novartis Investigative Site, Napoli, Campania, Italy
Novartis Investigative Site, Bologna, Emilia-Romagna, Italy
Novartis Investigative Site, Meldola (FC), Emilia-Romagna, Italy
Novartis Investigative Site, Modena, Emilia-Romagna, Italy
Novartis Investigative Site, Roma, Lazio, Italy
Novartis Investigative Site, Roma, Lazio, Italy
Novartis Investigative Site, Milano, Lombardia, Italy
Novartis Investigative Site, Rozzano (MI), Lombardia, Italy
Novartis Investigative Site, Candiolo (TO), Piemonte, Italy
Novartis Investigative Site, Arezzo, Toscana, Italy
Novartis Investigative Site, Terni, Umbria, Italy
Novartis Investigative Site, Negrar, Veneto, Italy
Novartis Investigative Site, Fukuoka, , Japan
Novartis Investigative Site, Hokkaido, , Japan
Novartis Investigative Site, Hokkaido, , Japan
Novartis Investigative Site, Kanagawa, , Japan
Novartis Investigative Site, Okayama, , Japan
Novartis Investigative Site, Osaka, , Japan
Novartis Investigative Site, Shizuoka, , Japan
Novartis Investigative Site, Tokyo, , Japan
Novartis Investigative Site, Tokyo, , Japan
Novartis Investigative Site, Tokyo, , Japan
Novartis Investigative Site, Yamagata, , Japan
Novartis Investigative Site, Daejeon, , Korea, Republic of
Novartis Investigative Site, Goyang-si, Gyeonggi-do, , Korea, Republic of
Novartis Investigative Site, Jeonju-si, , Korea, Republic of
Novartis Investigative Site, Seongnam-si Gyeonggi-do, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Songpa-gu, Seoul, , Korea, Republic of
Novartis Investigative Site, Luxembourg, , Luxembourg
Novartis Investigative Site, Gdansk, , Poland
Novartis Investigative Site, Konin, , Poland
Novartis Investigative Site, Krakow, , Poland
Novartis Investigative Site, Krakow, , Poland
Novartis Investigative Site, Lublin, , Poland
Novartis Investigative Site, Warszawa, , Poland
Novartis Investigative Site, Warszawa, , Poland
Novartis Investigative Site, Warszawa, , Poland
Novartis Investigative Site, Wroclaw, , Poland
Novartis Investigative Site, Arkhangelsk, , Russian Federation
Novartis Investigative Site, Barnaul, , Russian Federation
Novartis Investigative Site, Chelyabinsk, , Russian Federation
Novartis Investigative Site, Ekaterinburg, , Russian Federation
Novartis Investigative Site, Kazan, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Obninsk, , Russian Federation
Novartis Investigative Site, Omsk, , Russian Federation
Novartis Investigative Site, Rostov-na-Donu, , Russian Federation
Novartis Investigative Site, Ryazan, , Russian Federation
Novartis Investigative Site, Saint Petersburg, , Russian Federation
Novartis Investigative Site, St. Petersburg, , Russian Federation
Novartis Investigative Site, Stavropol, , Russian Federation
Novartis Investigative Site, Ufa,, , Russian Federation
Novartis Investigative Site, Banska Bystrica, , Slovakia
Novartis Investigative Site, Bratislava, , Slovakia
Novartis Investigative Site, Kosice, , Slovakia
Novartis Investigative Site, Martin, , Slovakia
Novartis Investigative Site, Zilina, , Slovakia
Novartis Investigative Site, Badalona, , Spain
Novartis Investigative Site, Barcelona, , Spain
Novartis Investigative Site, Cordoba, , Spain
Novartis Investigative Site, Dos Hermanas (Sevilla), , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Malaga, , Spain
Novartis Investigative Site, Oviedo, , Spain
Novartis Investigative Site, Sevilla, , Spain
Novartis Investigative Site, Valencia, , Spain
Novartis Investigative Site, Ankara, , Turkey
Novartis Investigative Site, Ankara, , Turkey
Novartis Investigative Site, Istanbul, , Turkey
Novartis Investigative Site, Izmir, , Turkey
Novartis Investigative Site, Brighton, , United Kingdom
Novartis Investigative Site, Cornwall, , United Kingdom
Novartis Investigative Site, Guildford, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, Manchester, , United Kingdom
Novartis Investigative Site, Preston, , United Kingdom
Novartis Investigative Site, Swansea, , United Kingdom
Novartis Investigative Site, Wolverhampton, , United Kingdom
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR